DOCSLIB.ORG

Strand Breaks for P53 Exon 6 and 8 Among Different Time Course of Folate Depletion Or Repletion in the Rectosigmoid Mucosa

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Strand Breaks for P53 Exon 6 and 8 Among Different Time Course of Folate Depletion Or Repletion in the Rectosigmoid Mucosa SUPPLEMENTAL FIGURE COLON p53 EXONIC STRAND BREAKS DURING FOLATE DEPLETION-REPLETION INTERVENTION Supplemental Figure Legend Strand breaks for p53 exon 6 and 8 among different time course of folate depletion or repletion in the rectosigmoid mucosa. The input of DNA was controlled by GAPDH. The data is shown as ΔCt after normalized to GAPDH. The higher ΔCt the more strand breaks. The P value is shown in the figure. SUPPLEMENT S1 Genes that were significantly UPREGULATED after folate intervention (by unadjusted paired t-test), list is sorted by P value Gene Symbol Nucleotide P VALUE Description OLFM4 NM_006418 0.0000 Homo sapiens differentially expressed in hematopoietic lineages (GW112) mRNA. FMR1NB NM_152578 0.0000 Homo sapiens hypothetical protein FLJ25736 (FLJ25736) mRNA. IFI6 NM_002038 0.0001 Homo sapiens interferon alpha-inducible protein (clone IFI-6-16) (G1P3) transcript variant 1 mRNA. Homo sapiens UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 GALNTL5 NM_145292 0.0001 (GALNT15) mRNA. STIM2 NM_020860 0.0001 Homo sapiens stromal interaction molecule 2 (STIM2) mRNA. ZNF645 NM_152577 0.0002 Homo sapiens hypothetical protein FLJ25735 (FLJ25735) mRNA. ATP12A NM_001676 0.0002 Homo sapiens ATPase H+/K+ transporting nongastric alpha polypeptide (ATP12A) mRNA. U1SNRNPBP NM_007020 0.0003 Homo sapiens U1-snRNP binding protein homolog (U1SNRNPBP) transcript variant 1 mRNA. RNF125 NM_017831 0.0004 Homo sapiens ring finger protein 125 (RNF125) mRNA. FMNL1 NM_005892 0.0004 Homo sapiens formin-like (FMNL) mRNA. ISG15 NM_005101 0.0005 Homo sapiens interferon alpha-inducible protein (clone IFI-15K) (G1P2) mRNA. SLC6A14 NM_007231 0.0005 Homo sapiens solute carrier family 6 (neurotransmitter transporter) member 14 (SLC6A14) mRNA. PI3 NM_002638 0.0007 Homo sapiens protease inhibitor 3 skin-derived (SKALP) (PI3) mRNA. SELL NM_000655 0.0008 Homo sapiens selectin L (lymphocyte adhesion molecule 1) (SELL) mRNA. TMPRSS9 NM_182973 0.0008 Homo sapiens polyserase 1 (LOC360200) mRNA. RILPL2 NM_145058 0.0008 Homo sapiens hypothetical protein MGC7036 (MGC7036) mRNA. LOC146206 XM_085383 0.0009 Homo sapiens hypothetical protein LOC146206 (LOC146206) mRNA. OAZ2 NM_002537 0.0009 Homo sapiens ornithine decarboxylase antizyme 2 (OAZ2) mRNA. LCE3C NM_178434 0.0009 Homo sapiens small proline rich-like (epidermal differentiation complex) 3A (SPRL3A) mRNA. CFB NM_001710 0.0011 Homo sapiens B-factor properdin (BF) mRNA. Homo sapiens matrix metalloproteinase 9 (gelatinase B 92kDa gelatinase 92kDa type IV collagenase) MMP9 NM_004994 0.0012 (MMP9) mRNA. LOC151658 XM_379205 0.0012 Homo sapiens hypothetical protein LOC151658 (LOC151658) mRNA. TESC NM_017899 0.0013 Homo sapiens hypothetical protein FLJ20607 (TSC) mRNA. CCDC102B NM_024781 0.0013 Homo sapiens hypothetical protein FLJ23594 (FLJ23594) mRNA. LOC400832 XM_378957 0.0013 Homo sapiens LOC400832 (LOC400832) mRNA. WDFY3 NM_178585 0.0013 Homo sapiens WD repeat and FYVE domain containing 3 (WDFY3) transcript variant 3 mRNA. CCL19 NM_006274 0.0014 Homo sapiens chemokine (C-C motif) ligand 19 (CCL19) mRNA. STK10 NM_005990 0.0014 Homo sapiens serine/threonine kinase 10 (STK10) mRNA. IRX6 NM_024335 0.0015 Homo sapiens iroquois homeobox protein 6 (IRX6) mRNA. ZNF570 NM_144694 0.0015 Homo sapiens hypothetical protein FLJ30791 (FLJ30791) mRNA. LOC388665 XM_371281 0.0016 Homo sapiens similar to DKFZP564K247 protein (LOC388665) mRNA. ADRA1A NM_033303 0.0016 Homo sapiens adrenergic alpha-1A- receptor (ADRA1A) transcript variant 2 mRNA. IL6 NM_000600 0.0017 Homo sapiens interleukin 6 (interferon beta 2) (IL6) mRNA. CCL20 NM_004591 0.0019 Homo sapiens chemokine (C-C motif) ligand 20 (CCL20) mRNA. DUOX2 NM_014080 0.0020 Homo sapiens dual oxidase 2 (DUOX2) mRNA. LOC151534 NM_138482 0.0020 Homo sapiens hypothetical protein BC009264 (LOC151534) mRNA. ANGPT1 NM_139290 0.0020 Homo sapiens angiopoietin 1 (ANGPT1) transcript variant 2 mRNA. GKN2 NM_182536 0.0020 Homo sapiens down-regulated in gastric cancer GDDR (GDDR) mRNA. TGFB3 NM_003239 0.0022 Homo sapiens transforming growth factor beta 3 (TGFB3) mRNA. LOC283547 XM_378454 0.0023 Homo sapiens hypothetical protein LOC283547 (LOC283547) mRNA. ADAMTSL4 NM_019032 0.0023 Homo sapiens thrombospondin repeat containing 1 (TSRC1) mRNA. CD7 NM_006137 0.0024 Homo sapiens CD7 antigen (p41) (CD7) mRNA. C17orf67 XM_378687 0.0025 Homo sapiens hypothetical protein LOC339210 (LOC339210) mRNA. MYR8 XM_028522 0.0025 Homo sapiens myosin heavy chain Myr 8 (MYR8) mRNA. Homo sapiens transcription factor 2 hepatic; LF-B3; variant hepatic nuclear factor (TCF2) transcript variant TCF2 NM_006481 0.0027 b mRNA. WFDC13 NM_172005 0.0027 Homo sapiens WAP four-disulfide core domain 13 (WFDC13) mRNA. LOC283403 XM_211028 0.0027 Homo sapiens hypothetical protein LOC283403 (LOC283403) mRNA. GIMAP5 NM_018384 0.0029 Homo sapiens immune associated nucleotide 4 like 1 (mouse) (IAN4L1) mRNA. KIAA1268 XM_291055 0.0029 Homo sapiens KIAA1268 protein (KIAA1268) mRNA. LOC388198 XM_373655 0.0029 Homo sapiens LOC400485 (LOC388198) mRNA. ECGF1 NM_001953 0.0030 Homo sapiens endothelial cell growth factor 1 (platelet-derived) (ECGF1) mRNA. KIAA0802 XM_031357 0.0030 Homo sapiens KIAA0802 protein (KIAA0802) mRNA. C15orf27 NM_152335 0.0030 Homo sapiens hypothetical protein FLJ38190 (FLJ38190) mRNA. IKBKE NM_014002 0.0030 Homo sapiens inhibitor of kappa light polypeptide gene enhancer in B-cells kinase epsilon (IKBKE) mRNA. KIAA1199 NM_018689 0.0031 Homo sapiens KIAA1199 protein (KIAA1199) mRNA. RNF145 NM_144726 0.0032 Homo sapiens hypothetical protein FLJ31951 (FLJ31951) mRNA. CLCNKB NM_000085 0.0033 Homo sapiens chloride channel Kb (CLCNKB) mRNA. MFAP2 NM_017459 0.0033 Homo sapiens microfibrillar-associated protein 2 (MFAP2) transcript variant 1 mRNA. MYH7B XM_371398 0.0033 Homo sapiens myosin heavy polypeptide 7B cardiac muscle beta (MYH7B) mRNA. GRIA2 NM_000826 0.0033 Homo sapiens glutamate receptor ionotropic AMPA 2 (GRIA2) mRNA. LOC124220 NM_145252 0.0035 Homo sapiens similar to common salivary protein 1 (LOC124220) mRNA. PRO0641 NM_014135 0.0035 Homo sapiens PRO0641 protein (PRO0641) mRNA. ZBED2 NM_024508 0.0036 Homo sapiens zinc finger BED domain containing 2 (ZBED2) mRNA. CXCL13 NM_006419 0.0038 Homo sapiens chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) (CXCL13) mRNA. CCR7 NM_001838 0.0039 Homo sapiens chemokine (C-C motif) receptor 7 (CCR7) mRNA. CD1A NM_001763 0.0039 Homo sapiens CD1A antigen a polypeptide (CD1A) mRNA. MICB NM_005931 0.0040 Homo sapiens MHC class I polypeptide-related sequence B (MICB) mRNA. DNMT2 NM_176086 0.0041 Homo sapiens DNA (cytosine-5-)-methyltransferase 2 (DNMT2) transcript variant f mRNA. LOC401051 XM_379174 0.0041 Homo sapiens LOC401051 (LOC401051) mRNA. LOC285192 XM_351525 0.0042 Homo sapiens similar to aquaporin 11 (LOC285192) mRNA. CDH11 NM_033664 0.0043 Homo sapiens cadherin 11 type 2 OB-cadherin (osteoblast) (CDH11) transcript variant 2 mRNA. LOC93082 NM_138397 0.0043 Homo sapiens hypothetical protein BC012317 (LOC93082) mRNA. LGALS2 NM_006498 0.0043 Homo sapiens lectin galactoside-binding soluble 2 (galectin 2) (LGALS2) mRNA. Homo sapiens plectin 1 intermediate filament binding protein 500kDa (PLEC1) transcript variant 11 PLEC1 NM_201384 0.0044 mRNA. SLA2 NM_175077 0.0044 Homo sapiens Src-like-adaptor 2 (SLA2) transcript variant 2 mRNA. Homo sapiens proteasome (prosome macropain) subunit beta type 9 (large multifunctional protease 2) PSMB9 NM_148954 0.0045 (PSMB9) transcript variant 2 mRNA. TRIM7 NM_203296 0.0045 Homo sapiens tripartite motif-containing 7 (TRIM7) transcript variant 3 mRNA. LCN2 NM_005564 0.0045 Homo sapiens lipocalin 2 (oncogene 24p3) (LCN2) mRNA. FCGR3A NM_000569 0.0045 Homo sapiens Fc fragment of IgG low affinity IIIa receptor for (CD16) (FCGR3A) mRNA. EIF5 NM_183004 0.0045 Homo sapiens eukaryotic translation initiation factor 5 (EIF5) transcript variant 2 mRNA. MGC4294 NM_024314 0.0046 Homo sapiens hypothetical protein MGC4294 (MGC4294) mRNA. CD72 NM_001782 0.0047 Homo sapiens CD72 antigen (CD72) mRNA. OVCH2 NM_198185 0.0048 Homo sapiens oviductin protease (OVTN) mRNA. LOC284425 XM_211459 0.0049 Homo sapiens hypothetical LOC284425 (LOC284425) mRNA. TCF7L2 NM_030756 0.0049 Homo sapiens transcription factor 7-like 2 (T-cell specific HMG-box) (TCF7L2) mRNA. RALGPS2 NM_018037 0.0049 Homo sapiens Ral-A exchange factor RalGPS2 (FLJ10244) mRNA. CTLA4 NM_005214 0.0050 Homo sapiens cytotoxic T-lymphocyte-associated protein 4 (CTLA4) mRNA. C11orf70 NM_032930 0.0050 Homo sapiens hypothetical protein MGC13040 (MGC13040) mRNA. FLJ25344 NM_182512 0.0051 Homo sapiens hypothetical protein FLJ25344 (FLJ25344) mRNA. ADAM21 NM_003813 0.0052 Homo sapiens a disintegrin and metalloproteinase domain 21 (ADAM21) mRNA. KCNJ13 NM_002242 0.0052 Homo sapiens potassium inwardly-rectifying channel subfamily J member 13 (KCNJ13) mRNA. EEF1DP3 NM_145293 0.0052 Homo sapiens similar to hypothetical protein FLJ20897 (LOC196549) mRNA. PAX9 NM_006194 0.0053 Homo sapiens paired box gene 9 (PAX9) mRNA. MEST NM_177525 0.0054 Homo sapiens mesoderm specific transcript homolog (mouse) (MEST) transcript variant 3 mRNA. Homo sapiens fascin homolog 2 actin-bundling protein retinal (Strongylocentrotus purpuratus) (FSCN2) FSCN2 NM_012418 0.0054 mRNA. C21orf96 NM_025143 0.0055 Homo sapiens chromosome 21 open reading frame 96 (C21orf96) mRNA. Homo sapiens myxovirus (influenza virus) resistance 1 interferon-inducible protein p78 (mouse) (MX1) MX1 NM_002462 0.0056 mRNA. KIAA0889 NM_152257 0.0056 Homo sapiens KIAA0889 protein (KIAA0889) mRNA. LOC374344 XM_350798
Load more

Recommended publications
  • Screening and Identification of Key Biomarkers in Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Screening and identification of key biomarkers in clear cell renal cell carcinoma based on bioinformatics analysis Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423889; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common types of malignancy of the urinary system. The pathogenesis and effective diagnosis of ccRCC have become popular topics for research in the previous decade. In the current study, an integrated bioinformatics analysis was performed to identify core genes associated in ccRCC. An expression dataset (GSE105261) was downloaded from the Gene Expression Omnibus database, and included 26 ccRCC and 9 normal kideny samples. Assessment of the microarray dataset led to the recognition of differentially expressed genes (DEGs), which was subsequently used for pathway and gene ontology (GO) enrichment analysis.
    [Show full text]
  • Reprogramming of Trna Modifications Controls the Oxidative Stress Response by Codon-Biased Translation of Proteins
    Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Chan, Clement T.Y. et al. “Reprogramming of tRNA Modifications Controls the Oxidative Stress Response by Codon-biased Translation of Proteins.” Nature Communications 3 (2012): 937. As Published http://dx.doi.org/10.1038/ncomms1938 Publisher Nature Publishing Group Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/76775 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Reprogramming of tRNA modifications controls the oxidative stress response by codon-biased translation of proteins Clement T.Y. Chan,1,2 Yan Ling Joy Pang,1 Wenjun Deng,1 I. Ramesh Babu,1 Madhu Dyavaiah,3 Thomas J. Begley3 and Peter C. Dedon1,4* 1Department of Biological Engineering, 2Department of Chemistry and 4Center for Environmental Health Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; 3College of Nanoscale Science and Engineering, University at Albany, SUNY, Albany, NY 12203 * Corresponding author: PCD, Department of Biological Engineering, NE47-277, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139; tel 617-253-8017; fax 617-324-7554; email [email protected] 2 ABSTRACT Selective translation of survival proteins is an important facet of cellular stress response. We recently demonstrated that this translational control involves a stress-specific reprogramming of modified ribonucleosides in tRNA.
    [Show full text]
  • Allele-Specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish
    Allele-specific Expression of Ribosomal Protein Genes in Interspecific Hybrid Catfish by Ailu Chen A dissertation submitted to the Graduate Faculty of Auburn University in partial fulfillment of the requirements for the Degree of Doctor of Philosophy Auburn, Alabama August 1, 2015 Keywords: catfish, interspecific hybrids, allele-specific expression, ribosomal protein Copyright 2015 by Ailu Chen Approved by Zhanjiang Liu, Chair, Professor, School of Fisheries, Aquaculture and Aquatic Sciences Nannan Liu, Professor, Entomology and Plant Pathology Eric Peatman, Associate Professor, School of Fisheries, Aquaculture and Aquatic Sciences Aaron M. Rashotte, Associate Professor, Biological Sciences Abstract Interspecific hybridization results in a vast reservoir of allelic variations, which may potentially contribute to phenotypical enhancement in the hybrids. Whether the allelic variations are related to the downstream phenotypic differences of interspecific hybrid is still an open question. The recently developed genome-wide allele-specific approaches that harness high- throughput sequencing technology allow direct quantification of allelic variations and gene expression patterns. In this work, I investigated allele-specific expression (ASE) pattern using RNA-Seq datasets generated from interspecific catfish hybrids. The objective of the study is to determine the ASE genes and pathways in which they are involved. Specifically, my study investigated ASE-SNPs, ASE-genes, parent-of-origins of ASE allele and how ASE would possibly contribute to heterosis. My data showed that ASE was operating in the interspecific catfish system. Of the 66,251 and 177,841 SNPs identified from the datasets of the liver and gill, 5,420 (8.2%) and 13,390 (7.5%) SNPs were identified as significant ASE-SNPs, respectively.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • Proteomic Identification of the Transcription Factors Ikaros And
    European School of Molecular Medicine (SEMM) University of Milan and University of Naples “Federico II” PhD degree in Systems Medicine (curriculum in Molecular Oncology) Settore disciplinare: BIO/11 Proteomic identification of the transcription factors Ikaros and Aiolos as new Myc interactors on chromatin Chiara Veronica Locarno Matricola: R10755 Center for Genomic Science IIT@SEMM, Milan Supervisor: Bruno Amati, PhD IEO, Milan Added Supervisor: Arianna Sabò, PhD IEO, Milan Academic year 2017-2018 Table of contents List of abbreviations ........................................................................................................... 4 List of figures ....................................................................................................................... 8 List of tables ....................................................................................................................... 11 Abstract .............................................................................................................................. 12 1. INTRODUCTION ......................................................................................................... 13 1.1 Myc ........................................................................................................................................ 13 1.1.1 Myc discovery and structure ........................................................................................... 13 1.1.2. Role of Myc in physiological and pathological conditions ...........................................
    [Show full text]
  • TASOR Is a Pseudo-PARP That Directs HUSH Complex Assembly and Epigenetic Transposon Control
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.974832; this version posted March 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. TASOR is a pseudo-PARP that directs HUSH complex assembly and epigenetic transposon control Christopher H. Douse1,‡, Iva A. Tchasovnikarova2,‡, Richard T. Timms2,‡, Anna V. Protasio2, Marta Seczynska2, Daniil M. Prigozhin1, Anna Albecka1,2, Jane Wagstaff3, James C. Williamson2, Stefan M.V. Freund3, Paul J. Lehner2*, Yorgo Modis1,2* 1 Molecular Immunity Unit, Department of Medicine, University of Cambridge, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, UK 2 Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK 3 Structural Studies Division, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0QH, UK Current addresses: Department of Experimental Medical Science, Lund University, Sölvegatan 19, Lund, Sweden (C.H.D.); The Gurdon Institute, Tennis Court Road, Cambridge, UK (I.A.T.); Department of Pathology, Tennis Court Road, Cambridge, UK (A.V.P.); Molecular Biophysics and Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA (D.M.P.) ‡These authors contributed equally *co-corresponding authors Keywords: Transcriptional repression; epigenetic silencing; antiretroviral response; genome stability; histone H3 lysine 9 methylation (H3K9me3); transposable element (TE); long interspersed nuclear element-1 (LINE-1); poly-ADP ribose polymerase (PARP); RNA-binding protein; RNA-induced transcriptional silencing; CUT&RUN; CUT&Tag; genome profiling 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.09.974832; this version posted March 11, 2020.
    [Show full text]
  • Dual Proteome-Scale Networks Reveal Cell-Specific Remodeling of the Human Interactome
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.19.905109; this version posted January 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dual Proteome-scale Networks Reveal Cell-specific Remodeling of the Human Interactome Edward L. Huttlin1*, Raphael J. Bruckner1,3, Jose Navarrete-Perea1, Joe R. Cannon1,4, Kurt Baltier1,5, Fana Gebreab1, Melanie P. Gygi1, Alexandra Thornock1, Gabriela Zarraga1,6, Stanley Tam1,7, John Szpyt1, Alexandra Panov1, Hannah Parzen1,8, Sipei Fu1, Arvene Golbazi1, Eila Maenpaa1, Keegan Stricker1, Sanjukta Guha Thakurta1, Ramin Rad1, Joshua Pan2, David P. Nusinow1, Joao A. Paulo1, Devin K. Schweppe1, Laura Pontano Vaites1, J. Wade Harper1*, Steven P. Gygi1*# 1Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA. 2Broad Institute, Cambridge, MA, 02142, USA. 3Present address: ICCB-Longwood Screening Facility, Harvard Medical School, Boston, MA, 02115, USA. 4Present address: Merck, West Point, PA, 19486, USA. 5Present address: IQ Proteomics, Cambridge, MA, 02139, USA. 6Present address: Vor Biopharma, Cambridge, MA, 02142, USA. 7Present address: Rubius Therapeutics, Cambridge, MA, 02139, USA. 8Present address: RPS North America, South Kingstown, RI, 02879, USA. *Correspondence: [email protected] (E.L.H.), [email protected] (J.W.H.), [email protected] (S.P.G.) #Lead Contact: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/2020.01.19.905109; this version posted January 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Protein Expression Analysis of an in Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets
    Journal of Personalized Medicine Article Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets Hisham F. Bahmad 1,2,3 , Wenjing Peng 4, Rui Zhu 4, Farah Ballout 1, Alissar Monzer 1, 1,5 6, , 1, , 4, , Mohamad K. Elajami , Firas Kobeissy * y , Wassim Abou-Kheir * y and Yehia Mechref * y 1 Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107-2020, Lebanon; [email protected] (H.F.B.); [email protected] (F.B.); [email protected] (A.M.); [email protected] (M.K.E.) 2 Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA 3 Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA 4 Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA; [email protected] (W.P.); [email protected] (R.Z.) 5 Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA 6 Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut 1107-2020, Lebanon * Correspondence: [email protected] (F.K.); [email protected] (W.A.-K.); [email protected] (Y.M.); Tel.: +961-1-350000 (ext. 4805) (F.K.); +961-1-350000 (ext. 4778) (W.A.K.); +1-806-834-8246 (Y.M.); Fax: +1-806-742-1289 (Y.M.); 961-1-744464 (W.A.K.) These authors have contributed equally to this work as joint senior authors.
    [Show full text]
  • PROTEOMIC ANALYSIS of HUMAN URINARY EXOSOMES. Patricia
    ABSTRACT Title of Document: PROTEOMIC ANALYSIS OF HUMAN URINARY EXOSOMES. Patricia Amalia Gonzales Mancilla, Ph.D., 2009 Directed By: Associate Professor Nam Sun Wang, Department of Chemical and Biomolecular Engineering Exosomes originate as the internal vesicles of multivesicular bodies (MVBs) in cells. These small vesicles (40-100 nm) have been shown to be secreted by most cell types throughout the body. In the kidney, urinary exosomes are released to the urine by fusion of the outer membrane of the MVBs with the apical plasma membrane of renal tubular epithelia. Exosomes contain apical membrane and cytosolic proteins and can be isolated using differential centrifugation. The analysis of urinary exosomes provides a non- invasive means of acquiring information about the physiological or pathophysiological state of renal cells. The overall objective of this research was to develop methods and knowledge infrastructure for urinary proteomics. We proposed to conduct a proteomic analysis of human urinary exosomes. The first objective was to profile the proteome of human urinary exosomes using liquid chromatography-tandem spectrometry (LC- MS/MS) and specialized software for identification of peptide sequences from fragmentation spectra. We unambiguously identified 1132 proteins. In addition, the phosphoproteome of human urinary exosomes was profiled using the neutral loss scanning acquisition mode of LC-MS/MS. The phosphoproteomic profiling identified 19 phosphorylation sites corresponding to 14 phosphoproteins. The second objective was to analyze urinary exosomes samples isolated from patients with genetic mutations. Polyclonal antibodies were generated to recognize epitopes on the gene products of these genetic mutations, NKCC2 and MRP4. The potential usefulness of urinary exosome analysis was demonstrated using the well-defined renal tubulopathy, Bartter syndrome type I and using the single nucleotide polymorphism in the ABCC4 gene.
    [Show full text]
  • Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in Humans
    Remote Ischemic Preconditioning (RIPC) Modifies Plasma Proteome in Humans Michele Hepponstall1,2,3,4, Vera Ignjatovic1,3, Steve Binos4, Paul Monagle1,3, Bryn Jones1,2, Michael H. H. Cheung1,2,3, Yves d’Udekem1,2, Igor E. Konstantinov1,2,3* 1 Haematology Research, Murdoch Childrens Research Institute; Melbourne, Victoria, Australia, 2 Cardiac Surgery Unit and Cardiology, Royal Children’s Hospital; Melbourne, Victoria, Australia, 3 Department of Paediatrics, The University of Melbourne; Melbourne, Victoria, Australia, 4 Bioscience Research Division, Department of Primary Industries, Melbourne, Victoria, Australia Abstract Remote Ischemic Preconditioning (RIPC) induced by brief episodes of ischemia of the limb protects against multi-organ damage by ischemia-reperfusion (IR). Although it has been demonstrated that RIPC affects gene expression, the proteomic response to RIPC has not been determined. This study aimed to examine RIPC induced changes in the plasma proteome. Five healthy adult volunteers had 4 cycles of 5 min ischemia alternating with 5 min reperfusion of the forearm. Blood samples were taken from the ipsilateral arm prior to first ischaemia, immediately after each episode of ischemia as well as, at 15 min and 24 h after the last episode of ischemia. Plasma samples from five individuals were analysed using two complementary techniques. Individual samples were analysed using 2Dimensional Difference in gel electrophoresis (2D DIGE) and mass spectrometry (MS). Pooled samples for each of the time-points underwent trypsin digestion and peptides generated were analysed in triplicate using Liquid Chromatography and MS (LC-MS). Six proteins changed in response to RIPC using 2D DIGE analysis, while 48 proteins were found to be differentially regulated using LC-MS.
    [Show full text]
  • Protein Identities in Evs Isolated from U87-MG GBM Cells As Determined by NG LC-MS/MS
    Protein identities in EVs isolated from U87-MG GBM cells as determined by NG LC-MS/MS. No. Accession Description Σ Coverage Σ# Proteins Σ# Unique Peptides Σ# Peptides Σ# PSMs # AAs MW [kDa] calc. pI 1 A8MS94 Putative golgin subfamily A member 2-like protein 5 OS=Homo sapiens PE=5 SV=2 - [GG2L5_HUMAN] 100 1 1 7 88 110 12,03704523 5,681152344 2 P60660 Myosin light polypeptide 6 OS=Homo sapiens GN=MYL6 PE=1 SV=2 - [MYL6_HUMAN] 100 3 5 17 173 151 16,91913397 4,652832031 3 Q6ZYL4 General transcription factor IIH subunit 5 OS=Homo sapiens GN=GTF2H5 PE=1 SV=1 - [TF2H5_HUMAN] 98,59 1 1 4 13 71 8,048185945 4,652832031 4 P60709 Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 - [ACTB_HUMAN] 97,6 5 5 35 917 375 41,70973209 5,478027344 5 P13489 Ribonuclease inhibitor OS=Homo sapiens GN=RNH1 PE=1 SV=2 - [RINI_HUMAN] 96,75 1 12 37 173 461 49,94108966 4,817871094 6 P09382 Galectin-1 OS=Homo sapiens GN=LGALS1 PE=1 SV=2 - [LEG1_HUMAN] 96,3 1 7 14 283 135 14,70620005 5,503417969 7 P60174 Triosephosphate isomerase OS=Homo sapiens GN=TPI1 PE=1 SV=3 - [TPIS_HUMAN] 95,1 3 16 25 375 286 30,77169764 5,922363281 8 P04406 Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens GN=GAPDH PE=1 SV=3 - [G3P_HUMAN] 94,63 2 13 31 509 335 36,03039959 8,455566406 9 Q15185 Prostaglandin E synthase 3 OS=Homo sapiens GN=PTGES3 PE=1 SV=1 - [TEBP_HUMAN] 93,13 1 5 12 74 160 18,68541938 4,538574219 10 P09417 Dihydropteridine reductase OS=Homo sapiens GN=QDPR PE=1 SV=2 - [DHPR_HUMAN] 93,03 1 1 17 69 244 25,77302971 7,371582031 11 P01911 HLA class II histocompatibility antigen,
    [Show full text]